Rising Popularity of E-cigarettes Among Belarusian Teenagers

Market by 2FIRSTS.ai
Nov.21.2023
Rising Popularity of E-cigarettes Among Belarusian Teenagers
According to sb.by, a nationwide study by the Belarusian Health Research Center reveals the increasing popularity of e-cigarettes among teenagers.

According to sb.by news, the Belarusian Center for Health Studies has been conducting nationwide representative surveys on smoking behavior among students for the past 18 years. This year, they have expanded their monitoring scope to include an investigation into the use of e-cigarettes.

 

A survey conducted across 39 schools with the participation of 3,493 students in grades 7-10 has revealed that e-cigarettes are highly popular among adolescents. The findings indicate that 15% of the surveyed students reported using e-cigarettes.

 

A survey has revealed that the number of e-cigarette users has increased as age increases, with 9th grade students aged 15 being the most prominent group. Additionally, there is a gender disparity in e-cigarette usage, as female students are less likely to believe that e-cigarettes are harmful compared to their male counterparts. The data shows that as age increases, there is a decrease in the suspicion regarding the harmful effects of e-cigarettes.

 

Meanwhile, as individuals grow older, the number of teenagers unwilling to give up smoking is also on the rise, with the utilization of smokeless tobacco growing threefold over the past five years.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA’s launch of a web-based PMTA system signals faster reviews and, 2Firsts experts say, a possible inflection point for the U.S. e-cigarette market’s shift out of the grey zone.
Dec.04
Thailand’s health minister rejects vaping as a smoking cessation alternative
Thailand’s health minister rejects vaping as a smoking cessation alternative
Thailand’s Public Health Minister Phatthana Phromphat has reaffirmed that the government does not support cigarettes or e-cigarettes in any form and opposes the use of e-cigarettes as a substitute for smoking cessation.
Dec.17 by 2FIRSTS.ai
Poll Shows Britons Favor Regulation Over Bans on Nicotine Pouches
Poll Shows Britons Favor Regulation Over Bans on Nicotine Pouches
A new poll commissioned by We Vape UK reveals that most Britons favor regulation — not prohibition — of nicotine pouches. The survey shows broad public support for harm-reduction policies and frustration with weak government regulation, contrasting sharply with Ireland’s recent decision to ban disposable vapes and impose strict limits on nicotine products.
Nov.25 by 2FIRSTS.ai
Lancet Study Finds Rising Use of Nicotine Pouches in Britain
Lancet Study Finds Rising Use of Nicotine Pouches in Britain
A study published in The Lancet has found that nicotine pouch use is increasing in Britain, particularly among young men. Usage among people aged 16 to 24 has risen sharply since early 2022.
Dec.17 by 2FIRSTS.ai
Russia’s Perm Region Finalises Law Banning E-Cigarettes from March Next Year
Russia’s Perm Region Finalises Law Banning E-Cigarettes from March Next Year
The Governor of Russia’s Perm Region has confirmed that the newly adopted regional law banning vapes will take effect on March 1, 2026, despite lobbying from manufacturers and pressure from the federal level. The law prohibits the sale of all vaping products within the region, with penalties for violators, including fines for kiosks operating in residential areas.
Nov.26 by 2FIRSTS.ai
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20